Skip to main content
BIOMM SA logo

BIOMM SA — Investor Relations & Filings

ISIN · BRBIOMACNOR2 SA Manufacturing
Open in API
Filings indexed 236 across all filing types
Latest filing 2026-05-07 Regulatory Filings
Country BR Brazil
Listing SA

About BIOMM SA

https://biomm.com/

BIOMM SA specializes in the development, manufacturing, and commercialization of complex biopharmaceuticals and biosimilar drug products. Founded as a spin-off from a major insulin producer, the company focuses on advanced treatments for chronic conditions, particularly diabetes. Its portfolio includes human and swine insulins produced via recombinant DNA techniques, alongside specialized delivery systems such as the Biopemm reusable device and Afrezza inhaled insulin. The organization operates a dedicated production facility for the manufacture of high-tech medications and maintains strategic partnerships to broaden its therapeutic reach, including the introduction of semaglutide treatments. The firm emphasizes quality and accessibility in biomedicines, leveraging technical expertise to provide innovative healthcare solutions for patients requiring specialized biological therapies.

Recent filings

Filing Released Lang Actions
FRE - Formulário de Referência
Regulatory Filings
2026-05-07 Portuguese
FCA - Formulário Cadastral
Regulatory Filings
2026-05-07 Portuguese
-
Director's Dealing Classification · 100% confidence The document is titled 'FORMULÁRIO CONSOLIDADO' and details 'Negociação de Administradores e Pessoas Ligadas' which translates to 'Trading of Administrators and Related Persons'. It lists detailed transactions of securities and derivatives by company directors and related persons, including quantities, prices, and volumes. There is no indication of financial results, management discussion, or other report types. The content is a report of personal share transactions by company directors and executives, which matches the definition of Director's Dealing filings. The document length is 6888 characters, which is sufficient to contain detailed transaction data, not just an announcement or certification. Therefore, the correct classification is Director's Dealing (DIRS).
2026-05-05 Portuguese
Deferimento do pedido de migração de segmento de listagem - Nível 2
Regulatory Filings Classification · 95% confidence The document is a notice to shareholders about the migration of the company's listing segment from Bovespa Mais to the Level 2 Corporate Governance segment on the B3 stock exchange. It is an announcement regarding a change in the company's listing status and governance level, not a full report or detailed financial document. The text is relatively short (2586 characters) and serves as an official communication to shareholders and the market about this change. This fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement that does not fit into more specific categories like Annual Report, Interim Report, or Capital Update.
2026-05-05 Portuguese
-
Governance Information Classification · 95% confidence The document is titled 'POLÍTICA DE NEGOCIAÇÃO DE VALORES MOBILIÁRIOS DA BIOMM S.A.' which translates to 'Policy on Trading of Securities of BIOMM S.A.' It details rules and procedures for insiders and related parties regarding trading securities, including definitions, prohibitions, individual investment plans, and reporting obligations. The content is regulatory and governance-related, focusing on internal policies to prevent insider trading and ensure compliance with CVM regulations (Brazilian Securities Commission). There is no financial data, earnings information, or report publication. It is not an announcement of a report but a governance policy document. Therefore, it fits best under Governance Information (CGR), which covers internal rules and governance practices.
2026-05-05 Portuguese
-
Environmental & Social Information Classification · 95% confidence The document is titled 'Código de Conduta' (Code of Conduct) and contains detailed sections on ethics, values, compliance, integrity, respect for legislation, anti-corruption, inclusion, diversity, and corporate governance principles. It is a comprehensive internal policy document aimed at guiding employee and third-party behavior within the company. There is no indication of financial data, earnings, audit results, or regulatory filings. It is not a report, announcement, or presentation related to financial performance or corporate governance structure changes. The content aligns with governance and compliance practices but is not a governance report per se. Given the nature of the document as a Code of Conduct, it best fits under Environmental & Social Information (SR) as it relates to social responsibility, ethics, and corporate governance principles from a social and ethical perspective rather than formal governance structure reporting (CGR). Therefore, the most appropriate classification is Environmental & Social Information (SR).
2026-05-05 Portuguese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.